Sarah Akerman, MD

Akerman is head of neuroscience and global scientific affairs at Jazz Pharmaceuticals.

Most recent by Sarah Akerman, MD

SPONSORED CONTENT
January 23, 2025
1 min watch
Save

VIDEO: Cannabidiol linked to improved seizure and nonseizure outcomes in epilepsy

LOS ANGELES — Treatment with cannabidiol led to improved seizure and nonseizure outcomes in patients with various forms of epilepsy, data show.